Emcure Pharmaceuticals Limited (BOM:544210)
1,451.85
-16.25 (-1.11%)
At close: Mar 5, 2026
52.03% (1Y)
| Market Cap | 275.55B +31.0% |
| Revenue (ttm) | 88.50B +17.2% |
| Net Income | 8.70B +43.2% |
| EPS | 45.90 +39.7% |
| Shares Out | n/a |
| PE Ratio | 31.68 |
| Forward PE | 25.14 |
| Dividend | 3.00 (0.21%) |
| Ex-Dividend Date | Aug 14, 2025 |
| Volume | 4,535 |
| Average Volume | 6,759 |
| Open | 1,470.60 |
| Previous Close | 1,468.10 |
| Day's Range | 1,435.95 - 1,492.00 |
| 52-Week Range | 890.00 - 1,585.50 |
| Beta | n/a |
| RSI | 50.32 |
| Earnings Date | Feb 4, 2026 |